Healthcare and Life Science
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services Dublin, Ireland, and Montreal, Canada, 01 October 2024: ERS Genomics Limited, the CRISPR licensing Company, and Université de Montréal (‘UdeM’), a leading Can...
Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development
Next generation of industry-leading Cyto-Mine platform will offer new capabilities to optimize single-cell analysis workflow efficiency Opens up new, multiplexed assays and applications for antibody discovery and cell line development, and allows entry into new markets such as cell ...
Challenges and advances in asthma treatment
An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre Asthma remains a persistent challenge in healthcare, affecting both adults and children alike. In a recent podcast, Dr. Andrew Potter, GP lead at Wadden Medical Center in Milton Keynes, shared his valuable insigh...
Know your customer: strategic considerations for AI-powered provider segmentation
Published in Life Science Leader, CRA’s Robert Broadnax, Eddie Li and Brian Carpenter co-authored an article “Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation,” focused on the strategic considerations for drug manufacturers in developing an AI-powered pr...
Owlstone Medical partners with the FDA to advance the identification of volatile organic compounds in breath and expand its Breath Biopsy VOC Atlas.
Collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures Owlstone will use the developed methods and techniques to enhance its work in the field of breath-based biomarkers of disease Project will also help extend ...
FUJIFILM Irvine Scientific Adds Key Products To Its Life Sciences Portfolio From FUJIFILM Wako Chemicals U.S.A.
Additional products in lab automation, lab chemicals and LAL expand complete solutions available directly from FUJIFILM Irvine Scientific to customers in US and Europe Sales agreement aligns business and commercial operations to maximize customer benefit SANTA ANA, Calif: FUJIFILM...
Transforming healthcare: the power of purpose-led partnerships
In this episode, Dr Bipin Patel sits down with Samuel Hollis, Country President and Managing Director at Novartis to explore the key elements of forming impactful healthcare partnerships. ...
Enterprise Therapeutics granted ‘rare pediatric disease designation’ in the US for novel cystic fibrosis investigational therapy ETD001
ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical trials in July 2024, expected to complete in 2025 Brighton, UK: Enterprise Therapeu...
Takeda’s Qdenga® - more campaigns needed before single-dose products arrive
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the dengue endemic vaccines market. ...
Steritas’ Pediatric Glucocorticoid Toxicity Index used by Alder Hey and Liverpool Trials Centre to assess steroid toxicity in children with juvenile idiopathic arthritis
Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children ...